David Shaw’s Precision BioSciences DTIL Stock Holding History

David Shaw’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,165	Closed	-$52.9K	–	4378
2023 Q3	$52.9K	Sell	5,165 -9,323	-64%	-$143K	﹤0.01%	3913
2023 Q2	$229K	Sell	14,488 -1,233	-8%	-$28.2K	﹤0.01%	3702
2023 Q1	$355K	Buy	15,721 +167	+1%	+$5.5K	﹤0.01%	3692
2022 Q4	$555K	Sell	15,554 -1,742	-10%	-$68.8K	﹤0.01%	3798
2022 Q3	$674K	Buy	17,296 +8,485	+96%	+$403K	﹤0.01%	3858
2022 Q2	$423K	Buy	+8,811	New	+$517K	﹤0.01%	4193
2020 Q4	–	Sell	-717	Closed	-$133K	–	3969
2020 Q3	$133K	Buy	+717	New	+$143K	﹤0.01%	3674
2019 Q4	–	Sell	-438	Closed	-$110K	–	3999
2019 Q3	$110K	Buy	+438	New	+$143K	﹤0.01%	3689

Other funds holding DTIL

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

David Shaw's DTIL Position: Q4 2023 in Review

David Shaw sold out of Precision BioSciences (DTIL) in Q4 2023, closing a stake of 5,165 shares — an estimated $52.9K sold.

David Shaw first reported a position in DTIL in Q3 2019 and held it in 8 quarters. The position peaked at $674K in Q3 2022. 65 funds tracked by Wall St. Rank hold DTIL as of Q4 2023.

David Shaw reported no remaining Precision BioSciences position as of Q4 2023 after selling out during the quarter.
David Shaw sold 5,165 Precision BioSciences shares in Q4 2023, an estimated $52.9K.
David Shaw first reported a position in Precision BioSciences in Q3 2019 and held it in 8 quarters.
David Shaw's Precision BioSciences position peaked at $674K in Q3 2022.
65 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.